Table 1.
Comparisons of baseline demographics and characteristics in patients with severe COVID-19
| Characteristics | Early use group (n = 12) | Late use group (n = 10) |
|---|---|---|
| Age (years) mean ± SD | 65.6 ± 5.6 | 74.6 ± 4.6 |
| Sex, No. (%) | ||
| Male | 6/12 (50%) | 6/10 (60%) |
| Coexisting disease, No. (%) | ||
| Hypertension | 7/12 (58.3%) | 4/10 (30%) |
| Diabetes | 3/12 (25%) | 3/10 (30%) |
| Malignant neoplasm | 2/12 (16.7%) | 1/10 (10%) |
| Symptoms | ||
| Fever | 9/12 (75%) | 7/10 (70%) |
| Cough | 6/12 (50%) | 3/10 (30%) |
| Sputum | 5/12 (41.7%) | 4/10 (40%) |
| Dyspnea | 5/12 (41.7%) | 4/10 (40%) |
| Myalgia | 5/12 (41.7%) | 2/10 (20%) |
| Fatigue | 5/12 (41.7%) | 1/10 (10%) |
| Poor oral intake | 4/12 (33.3%) | 1/10 (10%) |
| Initial score on ordinal scale | ||
| No limit of activity | 0 | 0 |
| Limit of activity but no O2 | 4/12 (33.3%) | 4/10 (40%) |
| O2 with nasal prong | 5/12 (41.7%) | 2/10 (20%) |
| O2 with facial mask | 0 | 0 |
| High flow nasal cannula | 3/12 (25%) | 3/10 (30%) |
| Non-invasive ventilation | 0 | 0 |
| Invasive ventilation | 0 | 0 |
| Baseline score missing | 0 | 1/10 (10%) |
| Initial PaO2/FiO2 ratio | 124.89 ± 42.60 | 133.35 ± 49.40 |
COVID-19, coronavirus disease 2019; SD, standard deviation
Data are expressed as mean ± SD or number (%)